?
Ricks David A
President, Chair, and CEO
Eli Lilly and Company
US, Indianapolis [HQ]
CIK
1538604
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
479,250
Price per Share :
$725.72
Equivalence :
$347,801,310.00
Transaction History
-
A479,250 Shares After TransactionValue : $353,331,855.00$28,304,885.92Transaction Date : 02/12/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
G440,858 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/08/24
-
Footnotes
-
-
Footnotes:#1 On February 8, 2024, the Reporting Person transferred 956 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's wife is the trustee and the Reporting Person's wife and children are beneficiaries. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.
-
M455,054 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/01/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
F441,814 Shares After TransactionValue : $285,239,536.54$8,547,876.40Transaction Date : 02/01/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
M1,975 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/17/24
-
Footnotes
-
-
Footnotes:#1 Reflects an adjustment of 1,139 shares that were inadvertently reported as indirectly owned on the reporting person's prior Form 4. Such shares are now being reported as directly owned.